Merck drug extends immune system fight to stomach cancer

* Merck plans to start Phase II study in first quarter 2015
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.